Shenzhen Weiguang Biological Products

SZSE:002880 Stock Report

Mkt Cap: CN¥5.7b

Shenzhen Weiguang Biological Products Financial Health

How is Shenzhen Weiguang Biological Products's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: 002880's short term assets (CN¥1.1B) exceed its short term liabilities (CN¥120.9M).

Long Term Liabilities: 002880's short term assets (CN¥1.1B) exceed its long term liabilities (CN¥229.5M).


Debt to Equity History and Analysis

Debt Level: 002880 has more cash than its total debt.

Reducing Debt: 002880's debt to equity ratio has increased from 1% to 10.2% over the past 5 years.

Debt Coverage: 002880's debt is well covered by operating cash flow (119.2%).

Interest Coverage: 002880 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies